Benitec Biopharma closes ~$30.5M equity offering; issues 2.043M shares and pre-funded warrants

Benitec Biopharma Inc.

Gross proceeds ~$30.5M from underwritten offering of 1.143M shares + 300K pre-funded warrants at $13.00/$12.999 per share.
Direct offering to Averill Master Fund and Averill Madison Master Fund of 900K shares at $13.00 per share.
Post-closing: 25,546,288 common shares outstanding; warrants for 5,876,866 common shares and 15,270,807 pre-funded warrants.
Pre-funded warrants have exercise price of $0.0001 per share.
All securities sold in concurrent offerings at same price of $13.00 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.